{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T16:49:19Z","timestamp":1648572559596},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.4065\/74.12.1302","type":"journal-article","created":{"date-parts":[[2012,1,19]],"date-time":"2012-01-19T18:55:09Z","timestamp":1326999309000},"page":"1302-1304","source":"Crossref","is-referenced-by-count":2,"title":["The Fen-Phen Controversy: Is Regression Another Piece of the Puzzle?"],"prefix":"10.4065","volume":"74","author":[{"given":"Richard W.","family":"Asinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/74.12.1302_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine [published correction appears in N Engl J Med. 1997,337:1783]","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1302_bib2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4065\/74.12.1191","article-title":"Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine","volume":"74","author":"Hensrud","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/74.12.1302_bib3","first-page":"1061","article-title":"Cardiac valvulopathy associated with exposure to fenfluramine or dexfcnfluramine: US Department of Health and Human Services interim public health recommendations, November 1997","volume":"46","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.4065\/74.12.1302_bib4","author":"Food and Drug Administration"},{"key":"10.4065\/74.12.1302_bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199708283370911","article-title":"Further cases of valvular heart disease associated with fenfluramine-phentermine [letter]","volume":"337","author":"Graham","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1302_bib6","first-page":"I773","article-title":"Valvular heart discase associated with fenfluramine-phentermine [Letter]","volume":"337","author":"Rasmussen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1302_bib7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/j.1550-8528.1998.tb00350.x","article-title":"The fen-phen finale: a study of weight loss and valvular heart disease","volume":"6","author":"Wadden","year":"1998","journal-title":"Obes Res"},{"key":"10.4065\/74.12.1302_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4158\/EP.5.1.17","article-title":"Echocardiographic assessment of patients receiving long-term treatment with ano-rexiant medications","volume":"5","author":"Bowen","year":"1999","journal-title":"Endocr Pract"},{"key":"10.4065\/74.12.1302_bib9","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJM199712113372414","article-title":"Valvular heart disease associated with fenfluramine-phentermine [letter]","volume":"337","author":"Kurz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1302_bib10","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0735-1097(99)00321-6","article-title":"Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectivcly followed for up to 30 months","volume":"34","author":"Burger","year":"1999","journal-title":"J Am Coll Cardlol"},{"key":"10.4065\/74.12.1302_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJM199809103391101","article-title":"The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs","volume":"339","author":"Khan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1302_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199809103391103","article-title":"An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine. sustained-release dexfenfluramine, or placebo","volume":"339","author":"Weissman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1302_bib13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199809103391102","article-title":"A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation","volume":"339","author":"Jick","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1302_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/j.1550-8528.1999.tb00414.x","article-title":"Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine","volume":"7","author":"Ryan","year":"1999","journal-title":"Obes Res"},{"key":"10.4065\/74.12.1302_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.ijo.0801020","article-title":"Dose-effect of fenfluramine use on the severity of valvular heart disease among fen-phen patients with valvulopathy","volume":"23","author":"Li","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.4065\/74.12.1302_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7326\/0003-4819-117-1-50","article-title":"Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations","volume":"117","author":"Redfield","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1302_bib17","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease: clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka","year":"1993","journal-title":"Circulation"},{"key":"10.4065\/74.12.1302_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.ijo.0800920","article-title":"Synergistic interactions between fenfluramine and phentermine","volume":"23","author":"Wellman","year":"1999","journal-title":"Inl J Obes Relat Metab Disord"},{"key":"10.4065\/74.12.1302_bib19","first-page":"312","article-title":"Valvulopathy or primary pulmonary hypertension as possible consequences of administering a serotonin uptake blocker with a monoamine oxidasc inhibitor (\u201cphen-fen\u201d) [editorial)","volume":"20","author":"Wurtman","year":"1999","journal-title":"Cardiovasc Rev Rep"},{"key":"10.4065\/74.12.1302_bib20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1161\/01.CIR.84.4.1625","article-title":"Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function","volume":"84","author":"Bonow","year":"1991","journal-title":"Circulation"},{"key":"10.4065\/74.12.1302_bib21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199809103391112","article-title":"Regression of multivalvular regurgitation after the cessation of fenfluramine and phentermine treatment [letter]","volume":"339","author":"Cannistra","year":"1998","journal-title":"N Engl J Med"},{"issue":"suppl 5","key":"10.4065\/74.12.1302_bib22","first-page":"S63","article-title":"Does valvulopathy in patients treated with appetite suppressants regress over time? [abstract]","volume":"23","author":"Ryan","year":"1999","journal-title":"Gilt J Obes Relat Metab Disord"},{"issue":"suppl 5","key":"10.4065\/74.12.1302_bib23","first-page":"S178","article-title":"Regression of heart-valve abnormalities after discontinuation of dexfenfluramine treatment [abstract]","volume":"23","author":"Mancini","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.4065\/74.12.1302_bib24","first-page":"1159","article-title":"Fen\/phen and valvular heart disease: if it sounds too bad to be true, perhaps it isn't [editorial]","volume":"34","author":"Schiller","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/74.12.1302_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0894-7317(14)80299-X","article-title":"Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers","volume":"3","author":"Klein","year":"1990","journal-title":"J Am Soc Echocardiogr"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611641633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611641633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:59:38Z","timestamp":1543280378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611641633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["S0025619611641633"],"URL":"https:\/\/doi.org\/10.4065\/74.12.1302","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}